Vanguard US Opportunities Ins USD Acc

Performance History28/02/2019
Growth of 1,000 (EUR)
Vanguard US Opportunities Ins USD Acc
Fund18.316.015.4-0.415.1
+/-Cat11.44.311.04.01.2
+/-Idx6.4-0.19.00.02.3
 
Key Stats
NAV
21/03/2019
 USD 921.72
Day Change 0.71%
Morningstar Category™ US Flex-Cap Equity
ISIN IE00B03HCY54
Fund Size (Mil)
20/03/2019
 USD 2785.90
Share Class Size (Mil)
20/03/2019
 USD 1986.63
Max Initial Charge -
Ongoing Charge
18/02/2019
  0.85%
Investment Objective: Vanguard US Opportunities Ins USD Acc
This actively managed fund seeks to provide long-term capital growth by investing in U.S. stocks with above-average earnings growth potential that is not reflected in current market prices.
Returns
Trailing Returns (GBP)21/03/2019
YTD15.58
3 Years Annualised18.40
5 Years Annualised17.54
10 Years Annualised23.33
12 Month Yield 0.00
Management
Manager Name
Start Date
Not Disclosed
08/04/2002
Inception Date
08/04/2002
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
Russell 3000 NR USDRussell 3000 TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Vanguard US Opportunities Ins USD Acc28/02/2019
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks99.930.0099.93
Bonds0.000.000.00
Cash0.000.000.00
Other0.070.000.07
Top 5 Regions%
United States90.65
Asia - Emerging3.47
Canada2.11
United Kingdom1.40
Europe - ex Euro1.32
Top 5 Sectors%
Healthcare30.49
Technology25.68
Industrials18.14
Consumer Cyclical11.34
Financial Services9.30
Top 5 HoldingsSector%
Abiomed IncHealthcareHealthcare4.16
Eli Lilly and CoHealthcareHealthcare3.58
Seattle Genetics IncHealthcareHealthcare3.01
Southwest Airlines CoIndustrialsIndustrials2.73
Nektar Therapeutics IncHealthcareHealthcare2.24
Vanguard US Opportunities Ins USD Acc